For the first time in the UK, the London Endocrine Centre (LEC) in Harley Street has installed echotherapy - a non-invasive ultrasound-based treatment for two pathologies (mainly affecting women): thyroid nodules and breast fibroadenoma.
For the first time in the UK, the London Endocrine Centre (LEC) in Harley Street has installed echotherapy - a non-invasive ultrasound-based treatment for two pathologies (mainly affecting women): thyroid nodules and breast fibroadenoma. The Clinical Services Journaleditor Alec Peacheycaught up with Dr Paul Jenkins at the LEC and Michael Leach, vice president (UK,NE, India, MEA) of Theraclion - a company specialised in leading-edge medical equipment for echotherapy.
Treating these two pathologies with surgery involves incisions, scars, general anaesthesia and hospitalisation. Echotherapy offers patients a non-invasive alternative in both of these diseases without a scar, hospitalisation, or general anaesthesia and with an immediate recovery. Echotherapy can treat fibroadenomas and benign thyroid nodules in a targeted way, respecting the integrity of the surrounding tissue.
With all these benefits it is perhaps surprising that adoption of treatment in the UK has taken so long.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
